Retatrutide | 10mg

Retatrutide is an advanced triple-receptor agonist research compound targeting GLP-1, GIP, and glucagon pathways. Developed for laboratory investigation of metabolic signaling mechanisms and energy homeostasis research.

• Purity: ≥98% (HPLC verified)
• Format: Lyophilized powder
• Quantity: 10mg per vial
• Batch-specific COA available

For research use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.